| View |
|
DR-XY47588
|
Lamivudine + Tenofovir disoproxil fumarate
|
Tenvir-L
|
300 mg/300 mg
|
Film Coated Tablet
|
-
|
Cipla Limited
|
India
|
-
|
07 December 2021
|
07 December 2024
|
| View |
|
DR-XY47586
|
Atazanavir (as sulfate) + Ritonavir
|
Synthivan
|
300 mg/100 mg
|
Film Coated Tablet
|
Antiviral Combination
|
Cipla Limited
|
India
|
Monitored Release
|
07 December 2021
|
07 December 2024
|
| View |
|
DR-XY47587
|
Atazanavir (as sulfate) + Ritonavir
|
Synthivan
|
300 mg/100 mg
|
Film Coated Tablet
|
Antiviral Combination
|
Cipla Limited
|
India
|
Monitored Release
|
07 December 2021
|
07 December 2024
|
| View |
|
DRP-10890
|
Cefepime (as hydrochloride) + Sulbactam (as sodium)
|
Novafime S
|
1g/500 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin/Beta-lactamase Inhibitor)
|
Swiss Parenterals Ltd.
|
India
|
Initial
|
14 December 2021
|
14 December 2026
|
| View |
|
DRP-10889
|
Cefepime(As Hydrochloride)
|
Cefimed 1000
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Yeluri Formulations Pvt. Ltd.
|
India
|
Initial
|
14 December 2021
|
14 December 2026
|
| View |
|
DR-XY 46236
|
Clobetasol propionate
|
Cleovate
|
500 mcg/g (0.05%w/w))
|
Cream
|
Corticosteroid
|
Curetech Skincare
|
India
|
Automatic Renewal
|
03 December 2021
|
01 February 2025
|
| View |
|
DRP-5833
|
Tranexamic Acid
|
Hemoxin
|
500 mg
|
Capsule
|
Anti-Fibrinolytic
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Renewal
|
02 November 2024
|
15 March 2030
|
| View |
|
DRP-5550-01
|
Iron
|
None
|
44 mg (equivalent to 220 mg Ferrous Sulfate) /5 mL
|
Syrup
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Automatic Renewal (Reissuance)
|
09 March 2023
|
12 May 2025
|
| View |
|
DRP-10862
|
Choline Salicylate + Benzalkonium Chloride
|
Zytee RB
|
0.9 g / 0.002 g
|
Gel
|
Topical Antipyretic/Antiseptic
|
Raptakos Brett & Co., Ltd.
|
India
|
Renewal (Variation)
|
06 December 2021
|
10 July 2025
|
| View |
|
DRP-5779-01
|
Prednisone
|
None
|
5mg
|
Tablet
|
Corticosteroid
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Automatic Renewal (Re-Issuance)
|
09 March 2023
|
25 February 2025
|
| View |
|
DRP-10833
|
Betaxolol (as hydrochloride)
|
Bertocil
|
5 mg/mL (0.5% w/v)
|
Ophthalmic Solution (Drops)
|
-
|
Laboratório Edol - Produtos Farmacêuticos, S.A.
|
Portugal
|
-
|
06 December 2021
|
06 December 2026
|
| View |
|
DR-XY28414
|
Camphor + Menthol + Methyl Salicylate +
Diphenhydramine (as hydrochloride) + Glycyrrhizic
Acid + Chlorhexidine
|
Skin Treasure (Bao Fu Ling)
|
40 mg/ 30 mg/20 mg/ 10 mg/ 3 mg/ 2 mg
|
Topical Ointment
|
-
|
Beijing Bao Shu Tang Sci-Tech Pharmaceutical Co.,
Ltd.
|
China
|
Automatic Renewal (Revalidation)
|
23 February 2023
|
31 December 2025
|
| View |
|
DR-XY44607
|
Telmisartan
|
None
|
40mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
-
|
06 December 2021
|
05 June 2025
|
| View |
|
DRP-1266
|
Salmeterol Xinafoate + Fluticasone Propionate
|
Salmeflo
|
25 mcg / 125 mcg per Actuation
|
Metered Dose Inhaler
|
Beta-2-Adrenoceptor Agonist/Corticosteroid
|
Lloyd Laboratories Pvt. Ltd.
|
India
|
Renewal
|
29 April 2023
|
18 April 2028
|
| View |
|
DRP-9856
|
Etoricoxib
|
Ricox
|
90 mg
|
Film-Coated Tablet
|
-
|
Saga Lifesciences Limited
|
India
|
-
|
03 December 2021
|
05 June 2025
|
| View |
|
DRP-10893
|
Cefepime (as hydrochloride)
|
Bacefime
|
1g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
NCPC Hebei Huamin Pharmaceutical Company Limited
|
China
|
Initial
|
14 December 2021
|
14 December 2026
|
| View |
|
DRP-10829
|
Multivitamins + Zinc + Selenium
|
Complivit Plus
|
Ascorbic acid (equivalent to 350 mg Sodium ascorbate) 311.15 mg; Retinol acetate (Vitamin A) 5000 IU; Cholecalciferol (Vitamin D3) 400 IU;dl-Alpha Tocopheryl Acetate (Vitamin E) 50 IU; Zinc (equivalent to 68.62 Zinc sulfate monohydrate) 25 mg ; Selenium ( equivalent to 1.38 Selenium enriched yeast) 2.76 mg
|
Capsule
|
-
|
San Marino Laboratories Corporation
|
Philippines
|
-
|
02 December 2021
|
02 December 2026
|
| View |
|
DR-XY44675
|
Ondansetron (as hydrochloride)
|
Otron
|
2 mg/mL (8mg/4mL)
|
Solution for Injection (IM/IV)
|
Antiemetic
|
Myungmoon Pharmaceuticals Co., Ltd.
|
Korea
|
Automatic Renewal
|
03 December 2021
|
22 June 2025
|
| View |
|
DRP-10845
|
Doxorubicin Hydrochloride
|
Doxoccord 50 LP
|
2 mg/mL (50 mg/25 mL)
|
Pegylated Liposomal
Concentrate Solution for Injection (IV Infusion)
|
Antineoplastic
|
Intas Pharmaceuticals Limited
|
India
|
Initial
|
06 December 2021
|
06 December 2026
|
| View |
|
DRP-10846
|
Doxorubicin Hydrochloride
|
Doxoccord 20 LP
|
2 mg/mL (20 mg/10 mL)
|
Pegylated Liposomal
Concentrate for Solution for Injection (IV Infusion)
|
Antineoplastic
|
Intas Pharmaceuticals Limited
|
India
|
Initial
|
06 December 2021
|
06 December 2026
|